Outset Medical raises $91M

What does Outset Medical do?

Outset Medical, is a pioneering medical technology company which always places the patient before the machine. It is focused on re-imagining the experience of dialysis care for patients who are suffering from kidney disease. The company’s human centered model is designed to dramatically improve not just the care experience for patients, their families, physicians and health care providers, but also cost efficiencies for providers. In order to achieve this goal, the company has brought together the most dedicated, creative minds from dialysis with dedicated and creative minds from other healthcare departments, with the belief that cross fertilization with hard work will lead the definite path to invention.

How much Outset Medical was funded?

 Outset Medical raised  $40M in Debt Financing on June 9, 2015 from CRG.

Previous funding

$60M in Series B funding on May 20, 2015 from The Vertical Group and Warburg Pincus

$51Min Series C funding on June 9, 2015 from The Vertical Group, CRG, Warburg Pincus, Perceptive Advisors, Fidelity Management & Research and Partner Fund Management (PFM)

What is next for Outset Medical?

The company will use the latest funding raised to start a controlled commercial introduction this year and for pursuing expanded FDA clearance for allowing patients to use Tablo at home.

More about Outset Medical

Outset Medical’s Tablo system is the first to combine consumer product simplicity, real time integrated water purification  and wireless connectivity for creating a 35 inch dialysis clinic on wheels. Tablo is cleared by the U.S. FDA for use in acute and chronic care settings such as dialysis clinics and hospitals. The company is dedicated to reimagining the experience of dialysis care for patients with kidney diseases by providing them great flexibility, independence and control with the chance of dramatically reducing costs for providers and healthcare system.